Alphatec Holdings, Inc. (ATEC) Insider Trading Activity

NASDAQ$10.89
Market Cap
$1.59B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
133 of 871
Rank in Industry
14 of 109

ATEC Insider Trading Activity

ATEC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$1,152,948
6
18
Sells
$12,539,900
27
82

Related Transactions

Demski David Mdirector
2
$545,900
0
$0
$545,900
Valentine Keithdirector
1
$255,450
0
$0
$255,450
Bakst Evandirector
1
$201,600
0
$0
$201,600
Pelizzon David R
2
$149,998
0
$0
$149,998
MCGINNIS KAREN Kdirector
0
$0
2
$517,795
$-517,795
Lish ScottCHIEF OPERATING OFFICER
0
$0
6
$1.98M
$-1.98M
Koning John ToddCHIEF FINANCIAL OFFICER
0
$0
2
$2.01M
$-2.01M
Sponsel DavidEVP, SALES
0
$0
7
$2.35M
$-2.35M
Hunsaker Craig EEVP, PEOPLE & CULTURE
0
$0
2
$2.47M
$-2.47M
Miles PatrickCEO
0
$0
8
$3.22M
$-3.22M

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.

Insider Activity of Alphatec Holdings, Inc.

Over the last 12 months, insiders at Alphatec Holdings, Inc. have bought $1.15M and sold $12.54M worth of Alphatec Holdings, Inc. stock.

On average, over the past 5 years, insiders at Alphatec Holdings, Inc. have bought $39.12M and sold $211.4M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Demski David M (director) — $545,900. Valentine Keith (director) — $255,450. Bakst Evan (director) — $201,600.

The last purchase of 16,978 shares for transaction amount of $100,000 was made by Pelizzon David R () on 2024‑08‑23.

List of Insider Buy and Sell Transactions, Alphatec Holdings, Inc.

2025-06-13SaleLish ScottCHIEF OPERATING OFFICER
22,727
0.0156%
$11.07
$251,588
+0.08%
2025-06-11SaleMCGINNIS KAREN Kdirector
3,963
0.0028%
$12.11
$47,992
-8.90%
2025-06-05SaleHunsaker Craig EEVP, PEOPLE & CULTURE
13,878
0.0094%
$12.36
$171,532
-7.62%
2025-06-04SaleHunsaker Craig EEVP, PEOPLE & CULTURE
186,122
0.128%
$12.34
$2.3M
-5.47%
2025-05-19SaleLish ScottCHIEF OPERATING OFFICER
55,375
0.0378%
$13.00
$719,875
-4.71%
2025-05-05SaleLish ScottCHIEF OPERATING OFFICER
12,000
0.0083%
$12.12
$145,440
+2.36%
2025-04-22SaleKoning John ToddCHIEF FINANCIAL OFFICER
37,500
0.0318%
$10.71
$401,625
+13.34%
2025-03-10SaleLish ScottCHIEF OPERATING OFFICER
27,994
0.0195%
$9.72
$272,102
+14.35%
2025-03-10SaleKoning John ToddCHIEF FINANCIAL OFFICER
165,121
0.1151%
$9.72
$1.6M
+14.35%
2025-03-07SaleMiles PatrickCEO
12,691
0.0089%
$10.64
$135,032
+5.59%
2025-03-06SaleSponsel DavidEVP, SALES
33,732
0.0235%
$10.83
$365,318
+2.23%
2025-03-03SaleMCGINNIS KAREN Kdirector
38,320
0.0266%
$12.26
$469,803
-9.98%
2025-02-27SaleLish ScottCHIEF OPERATING OFFICER
23,183
0.0157%
$12.03
$278,891
-8.66%
2025-02-26SaleMiles PatrickCEO
32,393
0.0229%
$10.89
$352,760
+0.72%
2025-02-25SaleSponsel DavidEVP, SALES
19,419
0.0134%
$10.41
$202,152
+4.83%
2025-02-24SaleSponsel DavidEVP, SALES
12,946
0.0092%
$10.73
$138,911
+2.83%
2025-02-06SaleLish ScottCHIEF OPERATING OFFICER
27,453
0.0186%
$11.49
$315,435
-3.94%
2025-02-05SaleMiles PatrickCEO
43,459
0.0302%
$11.95
$519,335
-8.20%
2025-02-03SaleSponsel DavidEVP, SALES
36,256
0.0248%
$11.42
$414,044
-3.99%
2025-01-30SaleMiles PatrickCEO
43,313
0.0305%
$12.03
$521,055
-6.04%
Total: 317
*Gray background shows transactions not older than one year

Insider Historical Profitability

7.01%
Miles PatrickCEO
5857603
4.0073%
$63.79M228
+42.98%
Hunsaker Craig EEVP, PEOPLE & CULTURE
1450018
0.992%
$15.79M134
<0.0001%
Lish ScottCHIEF OPERATING OFFICER
748918
0.5124%
$8.16M019
Sponsel DavidEVP, SALES
668977
0.4577%
$7.29M123
+38.21%
Koning John ToddCHIEF FINANCIAL OFFICER
466536
0.3192%
$5.08M17
<0.0001%
Pelizzon David R
331696
0.2269%
$3.61M90
<0.0001%
Demski David Mdirector
288441
0.1973%
$3.14M30
+10.67%
Valentine Keithdirector
82140
0.0562%
$894,504.6010
MCGINNIS KAREN Kdirector
68709
0.047%
$748,241.0102
Bakst Evandirector
50000
0.0342%
$544,500.0041
+23.02%
HEALTHPOINTCAPITAL PARTNERS II L P10 percent owner
21010565
14.3738%
$228.81M01
HGP II, LLC10 percent owner
21010565
14.3738%
$228.81M01
L-5 Healthcare Partners, LLC10 percent owner
11081538
7.5811%
$120.68M01
HealthpointCapital Partners LP10 percent owner
10777173
7.3729%
$117.36M02
HGP LLC10 percent owner
10777173
7.3729%
$117.36M02
Black Jeffrey G.EVP & CFO
620770
0.4247%
$6.76M26
+81.42%
Blackford Quentin S.director
572605
0.3917%
$6.24M10
<0.0001%
Kuyper DirkPresident and CEO
559128
0.3825%
$6.09M93
+4.53%
Berkowitz Mortimer III
555121
0.3798%
$6.05M72
+12.1%
Hiscock RonaldPresident and CEO
504075
0.3448%
$5.49M20
<0.0001%
Snider BrianEVP, Strat. Mktg. & Prod. Dev.
493007
0.3373%
$5.37M20
+65.38%
Asai MitsuoPresident, Alphatec Pacific
266610
0.1824%
$2.9M80
<0.0001%
Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC.
245638
0.168%
$2.67M03
Rydin Jeffrey Pdirector
243746
0.1668%
$2.65M01
Hochschuler Stephendirector
232183
0.1588%
$2.53M40
+144.98%
Rich TerryChief Executive Officer
207958
0.1423%
$2.26M30
+39.14%
Howell Kelli MariEVP, Clinical Strategies
205640
0.1407%
$2.24M10
+101.15%
Plunkett Michael JosephChief Operating Officer
199490
0.1365%
$2.17M20
<0.0001%
TULLIS JAMES L Ldirector
171962
0.1176%
$1.87M112
+42.97%
Ryan PatrickChief Operating Officer
160000
0.1095%
$1.74M10
<0.0001%
O'Neill MichaelChief Financial Officer
126222
0.0864%
$1.37M20
<0.0001%
Romanoski VickySenior VP, CAO and Sec.
103046
0.0705%
$1.12M40
<0.0001%
Northcutt TrentVP, Sales
98633
0.0675%
$1.07M10
<0.0001%
Garner EbunGeneral Counsel and SVP
95218
0.0651%
$1.04M90
<0.0001%
Mowry David Hdirector
92381
0.0632%
$1.01M03
Lubischer StephenVP, Sales
84773
0.058%
$923,177.9721
+10.34%
Hochberg Jasondirector
84375
0.0577%
$918,843.7520
<0.0001%
Bellucci Herbert JVP, Manufactuing & Intl.
76097
0.0521%
$828,696.3320
<0.0001%
Molson R Iandirector
75937
0.052%
$826,953.9321
+220.36%
CORBETT JAMESPresident and CEO
68204
0.0467%
$742,741.5620
<0.0001%
CROSS LESLIE Hdirector
65443
0.0448%
$712,674.27110
<0.0001%
Pritzker Jennifer N.10 percent owner
58000
0.0397%
$631,620.00190
<0.0001%
Oneil Stephendirector
56637
0.0387%
$616,776.9310
+4.38%
Weise ScottVP, Business Dev. & Marketing
55521
0.038%
$604,623.6910
<0.0001%
Williams Donald Allendirector
46433
0.0318%
$505,655.3720
+15.96%
Steven ReineckeChief Technology Officer, VP
46294
0.0317%
$504,141.6610
<0.0001%
Altman Elizabeth Anndirector
31158
0.0213%
$339,310.6202
Wulff Peter CCFO, VP and Treasurer
22000
0.0151%
$239,580.0050
+98.39%
Ravitch Richarddirector
20000
0.0137%
$217,800.0010
<0.0001%
Plotkin BrianVP, Information Technology
19749
0.0135%
$215,066.6110
<0.0001%
GLYNN JAMES Rdirector
15000
0.0103%
$163,350.0020
<0.0001%
Bradshaw KimberlyVP, Physician Services
11015
0.0075%
$119,953.3510
<0.0001%
TIMM JENS PETERVP, Research and Development
10528
0.0072%
$114,649.9230
+22.76%
Yasbek StevenCFO and VP
5800
0.004%
$63,162.0010
+16.31%
DIXON STEPHEN T DCFO, VP and Treasurer
2222
0.0015%
$24,197.5810
<0.0001%
Lacienski DanielExecutive VP, Operations
444
0.0003%
$4,835.1610
<0.0001%
Foster John10 percent owner
0
0%
$084
<0.0001%
Segal Pauldirector
0
0%
$044
+17.67%
*Gray background shows insiders who have made transactions during last year

ATEC Institutional Investors: Active Positions

Increased Positions125+50%16M+19.41%
Decreased Positions103-41.2%8M-9.08%
New Positions43New8MNew
Sold Out Positions37Sold Out4MSold Out
Total Postitions272+8.8%93M+10.32%

ATEC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$100,047.005.71%8.34M-235,753-2.75%2025-03-31
Vanguard Group Inc$71,628.004.09%5.97M+47,797+0.81%2024-12-31
American Century Companies Inc$59,869.003.42%4.99M+1M+36.53%2024-12-31
Braidwell Lp$51,078.002.92%4.26M+215,425+5.33%2024-12-31
Bnp Paribas Asset Management Holding S.A.$48,150.002.75%4.01M+1M+37.03%2024-12-31
Royal Bank Of Canada$38,223.002.18%3.19M+2M+171.21%2024-12-31
Bank Of America Corp /De/$35,524.002.03%2.96M-1M-32.55%2024-12-31
State Street Corp$35,006.002%2.92M-221,829-7.07%2024-12-31
Nuveen Asset Management, Llc$31,020.001.77%2.58M+1M+78.44%2024-12-31
Geode Capital Management, Llc$28,646.001.64%2.39M+24,283+1.03%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.